Suggestions
Andrew Hack, MD, PhD
Partner, Bain Capital Life Sciences
Andrew Hack, MD, PhD is a Partner at Bain Capital Life Sciences, a private equity fund that invests in various healthcare and life sciences companies globally.12 He joined Bain Capital in March 2019 and is based in Boston, Massachusetts.13
Professional Background
Dr. Hack has an extensive background in both medicine and finance:
Education::
- MD and PhD from the University of Chicago, specializing in molecular genetics and cell biology2
Career Highlights::
- Partner at Bain Capital Life Sciences (March 2019 - Present)1
- Chief Financial Officer at Editas Medicine, Inc. (prior to joining Bain Capital)2
- Portfolio manager at Millennium Management LLC, managing a healthcare-focused fund2
- Securities analyst for healthcare-focused hedge funds and investment banks2
- Director of Life Sciences at Reify Corporation, a life science tools and drug discovery company25
Role at Bain Capital
At Bain Capital Life Sciences, Dr. Hack is involved in investing in companies across various healthcare sectors, including:
- Biopharmaceuticals
- Specialty pharmaceuticals
- Medical devices
- Diagnostics
- Enabling life science technologies1
The fund focuses on companies that drive medical innovation and improve the lives of patients with unmet medical needs.1
Board Positions
Dr. Hack serves on the board of directors for several companies, including:
- Affinivax, Inc.
- Allena Pharmaceuticals, Inc.
- Atea Pharmaceuticals, Inc.
- BCLS Acquisition Corp.
- Dynavax Technologies, Inc.
- Imperative Care, Inc.
- JenaValve Technology, Inc.
- Mersana Therapeutics, Inc.
- Xilio Therapeutics24
His extensive experience in both the medical and financial sectors makes him a valuable asset to Bain Capital and the companies in which they invest.
